Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2025)
Adaptive Biotechnologies (ADPT) has disclosed Change in Acquisitions & Divestments for 8 consecutive years, with $39.1 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 41.62% to $39.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $222.6 million through Dec 2025, down 31.65% year-over-year, with the annual reading at $222.6 million for FY2025, 31.65% down from the prior year.
- Change in Acquisitions & Divestments hit $39.1 million in Q4 2025 for Adaptive Biotechnologies, down from $50.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $155.0 million in Q4 2021 to a low of $35.0 million in Q2 2022.
- Historically, Change in Acquisitions & Divestments has averaged $98.8 million across 5 years, with a median of $95.8 million in 2022.
- Biggest five-year swings in Change in Acquisitions & Divestments: crashed 75.78% in 2022 and later surged 301.15% in 2023.
- Year by year, Change in Acquisitions & Divestments stood at $155.0 million in 2021, then plummeted by 54.82% to $70.0 million in 2022, then surged by 80.63% to $126.5 million in 2023, then plummeted by 47.04% to $67.0 million in 2024, then tumbled by 41.62% to $39.1 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for ADPT at $39.1 million in Q4 2025, $50.9 million in Q3 2025, and $55.1 million in Q2 2025.